Literature DB >> 27918880

Racial Differences in HIV and HCV Risk Behaviors, Transmission, and Prevention Knowledge among Non-Treatment-Seeking Individuals with Opioid Use Disorder.

Verena E Metz1, Maria A Sullivan2, Jermaine D Jones3, Elizabeth Evans4, Rachel Luba5, Jonathan Vogelman5, Sandra D Comer5.   

Abstract

In light of New York's recently reinforced strategy to end the AIDS epidemic by expanding testing, treatment, and access to pre-exposure prophylaxis (PrEP), we assessed drug use and sexual risk behaviors, along with HIV/Hepatitis C virus (HCV) transmission and prevention knowledge among non-treatment-seeking adults with opioid use disorder (OUD) in New York City. Over the course of 18 months, volunteers screening for research studies in the Opioid Laboratory at the New York State Psychiatric Institute completed a locally developed self-assessment questionnaire. A total of 138 adults with OUD (24 female, 114 male) with a mean age of 46.5 years (SD = 9.5 yrs) were assessed. Significant differences among the four racial/ethnic subgroups (n = 65 African-Americans, n = 34 Hispanics, n = 31 Caucasians or Whites, n = 8 Multiracial) were found. Whites were the youngest (p = 0.001), most frequently injecting drugs (p < 0.001), and engaged more often in risky drug use and sexual behaviors, although their virus transmission knowledge was comparable to that of the other subgroups. Few participants had heard about PrEP. White opioid users showed the most risk behaviors among races/ethnicities, despite comparable prevention knowledge. Better HIV/HCV prevention interventions targeting individuals with opioid use disorders who are not currently in treatment would be desirable, given their large health burden.

Entities:  

Keywords:  Ethnicities; HIV; Hepatitis C; opioid users; prevention; risk behaviors

Mesh:

Year:  2016        PMID: 27918880      PMCID: PMC5950713          DOI: 10.1080/02791072.2016.1259518

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  16 in total

1.  Means to an end. Cities, states, and provinces are gearing up to halt their AIDS epidemics—though the definition of success varies.

Authors:  Jon Cohen
Journal:  Science       Date:  2015-07-16       Impact factor: 47.728

2.  The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study.

Authors:  Louisa Degenhardt; Fiona Charlson; Bradley Mathers; Wayne D Hall; Abraham D Flaxman; Nicole Johns; Theo Vos
Journal:  Addiction       Date:  2014-04-24       Impact factor: 6.526

Review 3.  Relationship between Nonmedical Prescription-Opioid Use and Heroin Use.

Authors:  Wilson M Compton; Christopher M Jones; Grant T Baldwin
Journal:  N Engl J Med       Date:  2016-01-14       Impact factor: 91.245

4.  Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013.

Authors:  Ashly E Jordan; Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Denis Nash; David C Perlman
Journal:  Drug Alcohol Depend       Date:  2015-04-13       Impact factor: 4.492

5.  Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.

Authors:  Anil G Suryaprasad; Jianglan Z White; Fujie Xu; Beth-Ann Eichler; Janet Hamilton; Ami Patel; Shadia Bel Hamdounia; Daniel R Church; Kerri Barton; Chardé Fisher; Kathryn Macomber; Marisa Stanley; Sheila M Guilfoyle; Kristin Sweet; Stephen Liu; Kashif Iqbal; Rania Tohme; Umid Sharapov; Benjamin A Kupronis; John W Ward; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2014-08-11       Impact factor: 9.079

6.  Racial/ethnic differences in the rates and correlates of HIV risk behaviors among drug abusers.

Authors:  Audrey J Brooks; Yuliya Lokhnygina; Christina S Meade; Jennifer Sharpe Potter; Donald A Calsyn; Shelly F Greenfield
Journal:  Am J Addict       Date:  2013 Mar-Apr

7.  Racial/ethnic differences in trends in heroin use and heroin-related risk behaviors among nonmedical prescription opioid users.

Authors:  Silvia S Martins; Julian Santaella-Tenorio; Brandon D L Marshall; Adriana Maldonado; Magdalena Cerdá
Journal:  Drug Alcohol Depend       Date:  2015-04-02       Impact factor: 4.492

8.  Providing ART to HIV Seropositive Persons Who Use Drugs: Progress in New York City, Prospects for "Ending the Epidemic".

Authors:  Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Jonathan Feelemyer; Holly Hagan; Hannah L F Cooper; Aimee N C Campbell; Susan Tross; David C Perlman
Journal:  AIDS Behav       Date:  2016-02

Review 9.  Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattention.

Authors:  Steffanie A Strathdee; Steven Shoptaw; Typhanye Penniman Dyer; Vu Minh Quan; Apinun Aramrattana
Journal:  Curr Opin HIV AIDS       Date:  2012-07       Impact factor: 4.283

10.  Racial disparities in HIV prevalence and risk behaviors among injection drug users and members of their risk networks.

Authors:  Chyvette Williams; Marlene Eisenberg; Julie Becher; Annet Davis-Vogel; Danielle Fiore; David Metzger
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

View more
  6 in total

1.  Suboptimal HIV Pre-exposure Prophylaxis Awareness and Willingness to Use Among Women Who Use Drugs in the United States: A Systematic Review and Meta-analysis.

Authors:  Chen Zhang; James McMahon; Janie Simmons; L Lauren Brown; Robertson Nash; Yu Liu
Journal:  AIDS Behav       Date:  2019-10

2.  Opioid-related overdose deaths among African Americans: Implications for research, practice and policy.

Authors:  Danelle Stevens-Watkins
Journal:  Drug Alcohol Rev       Date:  2020-04-12

3.  Trends in Black and White Opioid Mortality in the United States, 1979-2015.

Authors:  Monica J Alexander; Mathew V Kiang; Magali Barbieri
Journal:  Epidemiology       Date:  2018-09       Impact factor: 4.822

4.  The HIV pre-exposure prophylaxis continuum of care among women who inject drugs: A systematic review.

Authors:  Danielle Guy; Jason Doran; Trenton M White; Lena van Selm; Teymur Noori; Jeffrey V Lazarus
Journal:  Front Psychiatry       Date:  2022-08-26       Impact factor: 5.435

5.  The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review.

Authors:  Colleen B Mistler; Michael M Copenhaver; Roman Shrestha
Journal:  AIDS Behav       Date:  2021-05

6.  Pre-Exposure Prophylaxis (PrEP) for HIV Infection in Cisgender and Transgender Women in the U.S.: A Narrative Review of the Literature.

Authors:  Aleta Baldwin; Brenda Light; Waridibo E Allison
Journal:  Arch Sex Behav       Date:  2021-06-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.